McErlean E - Search Results

1

Assessment of the clinical effects of cholesteryl ester transfer protein inhibition with evacetrapib in patients at high-risk for vascular outcomes: Rationale and design of the ACCELERATE trial.

Nicholls SJ, Lincoff AM, Barter PJ, Brewer HB, Fox KA, Gibson CM, Grainger C, Menon V, Montalescot G, Rader D, Tall AR, McErlean E, Riesmeyer J, Vangerow B, Ruotolo G, Weerakkody GJ, Nissen SE. Nicholls SJ, et al. Among authors: mcerlean e. Am Heart J. 2015 Dec;170(6):1061-9. doi: 10.1016/j.ahj.2015.09.007. Epub 2015 Sep 16. Am Heart J. 2015. PMID: 26678626 Clinical Trial.

2

Ability of troponins to predict adverse outcomes in patients with renal insufficiency and suspected acute coronary syndromes: a case-matched study.

Van Lente F, McErlean ES, DeLuca SA, Peacock WF, Rao JS, Nissen SE. Van Lente F, et al. Among authors: mcerlean es. J Am Coll Cardiol. 1999 Feb;33(2):471-8. doi: 10.1016/s0735-1097(98)00592-0. J Am Coll Cardiol. 1999. PMID: 9973028 Free article.

3

Prediction of short- and long-term outcomes by troponin T levels in low-risk patients evaluated for acute coronary syndromes.

Peacock WF IV, Emerman CL, McErlean ES, Deluca SA, van Lente F, Rao JS, Nissen SE. Peacock WF IV, et al. Among authors: mcerlean es. Ann Emerg Med. 2000 Mar;35(3):213-20. Ann Emerg Med. 2000. PMID: 10692186

4

Comparison of troponin T versus creatine kinase-MB in suspected acute coronary syndromes.

McErlean ES, Deluca SA, van Lente F, Peacock F 4th, Rao JS, Balog CA, Nissen SE. McErlean ES, et al. Am J Cardiol. 2000 Feb 15;85(4):421-6. doi: 10.1016/s0002-9149(99)00766-3. Am J Cardiol. 2000. PMID: 10728944

5

The vulnerable coronary plaque.

Schoenhagen P, McErlean ES, Nissen SE. Schoenhagen P, et al. Among authors: mcerlean es. J Cardiovasc Nurs. 2000 Oct;15(1):1-12. doi: 10.1097/00005082-200010000-00002. J Cardiovasc Nurs. 2000. PMID: 11061217 Review.

6

Using troponin T to diagnose acute coronary syndromes.

McErlean E, Van Lente CF, Nissen SE. McErlean E, et al. Cleve Clin J Med. 2000 Nov;67(11):843-9. doi: 10.3949/ccjm.67.11.843. Cleve Clin J Med. 2000. PMID: 11104335 Free article.

7

Normal CK, elevated MB predicts complications in acute coronary syndromes.

Peacock WF, Emerman CL, McErlean ES, DeLuca SA, VanLente F, Lowrie M, Rao JS, Nissen SE. Peacock WF, et al. Among authors: mcerlean es. J Emerg Med. 2001 May;20(4):385-90. doi: 10.1016/s0736-4679(01)00317-1. J Emerg Med. 2001. PMID: 11348820

8

Troponin T in elders with suspected acute coronary syndromes.

Noeller TP, Meldon SW, Peacock WF, Emerman CL, McErlean ES, Vanlente F, Nissen SE. Noeller TP, et al. Among authors: mcerlean es. Am J Emerg Med. 2003 Jul;21(4):293-7. doi: 10.1016/s0735-6757(03)00081-0. Am J Emerg Med. 2003. PMID: 12898485

9

Prognostic value of myeloperoxidase in patients with chest pain.

Brennan ML, Penn MS, Van Lente F, Nambi V, Shishehbor MH, Aviles RJ, Goormastic M, Pepoy ML, McErlean ES, Topol EJ, Nissen SE, Hazen SL. Brennan ML, et al. Among authors: mcerlean es. N Engl J Med. 2003 Oct 23;349(17):1595-604. doi: 10.1056/NEJMoa035003. N Engl J Med. 2003. PMID: 14573731 Free article.

10

Risk stratification for patients undergoing nonurgent percutaneous coronary intervention using N-terminal pro-B-type natriuretic peptide: a Clopidogrel for the Reduction of Events During Observation (CREDO) substudy.

Tang WH, Steinhubl SR, Van Lente F, Brennan D, McErlean E, Maroo A, Francis GS, Topol EJ. Tang WH, et al. Among authors: mcerlean e. Am Heart J. 2007 Jan;153(1):36-41. doi: 10.1016/j.ahj.2006.10.011. Am Heart J. 2007. PMID: 17174634

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

50 results

Search Page

Filters